Welcome to our dedicated page for Adm Tronics SEC filings (Ticker: ADMT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ADM Tronics’ medical-device disclosures can feel like a maze of FDA jargon, R&D accounting notes, and segment data. If you have ever searched for “ADM Tronics SEC filings explained simply” or wondered how insider trades align with clinical milestones, you know the challenge. Our platform tackles that complexity head-on, turning dense reports into clear takeaways you can use today.
Stock Titan’s AI reads every submission the moment it hits EDGAR, translating the numbers and narratives behind each form. Whether you need the ADM Tronics quarterly earnings report 10-Q filing to compare R&D spend, or want alerts on ADM Tronics Form 4 insider transactions real-time, the data arrives in plain English alongside key metrics. You will also find:
- ADM Tronics insider trading Form 4 transactions with contextual charts
- ADM Tronics annual report 10-K simplified so pipeline costs and device margins stand out
- ADM Tronics proxy statement executive compensation mapped to performance goals
- ADM Tronics 8-K material events explained—from FDA clearances to manufacturing updates
Need deeper insight? Our dashboards pair AI summaries with side-by-side comparisons, giving you ADM Tronics earnings report filing analysis in seconds. By understanding ADM Tronics SEC documents with AI, professionals can track ADM Tronics executive stock transactions Form 4, gauge regulatory progress, and spot trends that influence valuation—all without slogging through hundreds of pages.
ADM Tronics (ADMT) filed its Q2 FY2025 (quarter ended September 30, 2025). Quarterly revenue was $887,498, up from $840,036, led by Electronics, while Engineering softened. The quarter posted a net loss of $114,672, largely reflecting a $111,000 unrealized loss on investments. For the six months, revenue was $1,861,173 and net income was $212,962 as stronger first-half results offset the Q2 investment loss.
Gross margin for the quarter was $375,797 on cost of sales of $511,701. Operating expenses fell year over year to $373,244. Cash and cash equivalents were $321,224, with operating cash outflow of $63,282 for the six months. The balance sheet shows total assets of $2,160,123, liabilities of $1,279,699, and stockholders’ equity of $880,424. The line of credit balance was $379,594.
Risk signals stood out. Management disclosed substantial doubt about the company’s ability to continue as a going concern for one year from November 13, 2025. Disclosure controls and procedures were deemed not effective due to staffing and segregation‑of‑duties limitations. Customer concentration remained high, with two customers contributing 46% of quarterly revenue.
FAQ
What is the current stock price of Adm Tronics (ADMT)?
What is the market cap of Adm Tronics (ADMT)?
